U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07660029) titled 'BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote Monitoring in Rheumatoid Arthritis' on June 03.
Brief Summary: The BloodTrackR Usability and Concordance Study (BUCS) is evaluating a novel home-based blood collection device and companion mobile application for people with rheumatoid arthritis. Participants will use the BloodTrackR device to collect a finger-prick blood sample at home and complete symptom assessments through the app.
The study will assess how easy the device and app are to use, whether participants can successfully collect high-quality blood sampl...